Here, hepatic CEBPA expression was found to be decreased during MASH progression both in humans and mice, and hepatic CEBPA mRNA was negatively correlated with MASH fibrosis in the human liver. Here, CEBPA is linked to metabolic dysfunction-associated steatohepatitis.